MicroPort Scientific Corporation

Research MicroPort Scientific Corporation (MSK) on Bullrun: market cap EUR 1.40B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 1.40B.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 994.91MUSD 48.52M-USD 32.63M55.6%0.02USD 682.51MUSD 1.60BUSD 980.82M
FY2024USD 1.03B-USD 214.04M-USD 158.10M55.7%n/aUSD 713.00MUSD 1.69BUSD 603.47M
FY2023USD 950.73M-USD 477.63M-USD 430.99M56.0%-0.27USD 1.02BUSD 1.70BUSD 757.82M
FY2022USD 840.83M-USD 436.52M-USD 600.58M59.7%-0.25USD 1.20BUSD 1.47BUSD 1.14B
FY2021USD 778.64M-USD 276.48M-USD 505.45M63.2%-0.17USD 1.75BUSD 1.24BUSD 1.49B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-14EUR 1.40Bn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

YearDividends/share
FY20210 USD

About MicroPort Scientific Corporation

MicroPort Scientific Corporation, together with its subsidiaries, engages in the innovating, manufacturing, and marketing medical devices globally in the People's Republic of China, the United States of America, Europe, Middle East and Africa, Japan, and internationally. The company's Cardiovascular Devices segment offers medical solutions for the treatment of coronary artery-related diseases; and coronary stents, related delivery systems, balloon catheters, accessories, and active devices.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is MicroPort Scientific Corporation's market cap?

MicroPort Scientific Corporation's market capitalization is EUR 1.40B.

What does MicroPort Scientific Corporation do?

MicroPort Scientific Corporation, together with its subsidiaries, engages in the innovating, manufacturing, and marketing medical devices globally in the People's Republic of China, the United States of America, Europe, Middle East and Africa, Japan, and internationally. The company's Cardiovascular Devices segment offers medical solutions for the treatment of coronary artery-related diseases; and coronary stents, related delivery systems, balloon catheters, accessories, and active devices.